Essex Woodlands Management’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-12,319
Closed -$17K 11
2014
Q4
$17K Hold
12,319
0.01% 10
2014
Q3
$10K Hold
12,319
﹤0.01% 10
2014
Q2
$28K Hold
12,319
0.01% 10
2014
Q1
$37K Hold
12,319
0.01% 10
2013
Q4
$39K Hold
12,319
0.02% 10
2013
Q3
$34K Hold
12,319
0.02% 10
2013
Q2
$31K Buy
+12,319
New +$64.6K 0.02% 10

Other funds holding ECTE

Essex Woodlands Management's ECTE Position: Q1 2015 in Review

Essex Woodlands Management sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q1 2015, closing a stake of 12,319 shares — an estimated $17K sold.

Essex Woodlands Management first reported a position in ECTE in Q2 2013 and held it in 7 quarters. The position peaked at $39K in Q4 2013. 18 funds tracked by Wall St. Rank hold ECTE as of Q1 2015.

  • Essex Woodlands Management reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q1 2015 after selling out during the quarter.
  • Essex Woodlands Management sold 12,319 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q1 2015, an estimated $17K.
  • Essex Woodlands Management first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q2 2013 and held it in 7 quarters.
  • Essex Woodlands Management's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $39K in Q4 2013.
  • 18 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q1 2015.

Based on Essex Woodlands Management's 13F filing for Q1 2015, filed 8 May 2015.